As a substantial portion of long-term anti-VEGF drug-treated patients appeared to have retinal thinning, a pathological characteristic of retinal degeneration [16,19], BDNF and/or other neurotrophins may be particularly useful in improving the safety of long-term anti-VEGF treatment for BRB disorders. The gene discussed is VEGFA; the disease is retinal degeneration.